Revvityvs.Waters Corporation
RVTY vs WAT · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Waters Corporation is about 3.1× larger than Revvity by market cap; Revvity trades at the lower P/E (55.1 vs 245.9); year to date, Revvity leads (+27.1% vs +8.1%).
Side by side
| RVTY | WAT | |
|---|---|---|
| Market cap | $13.1B | $40.9B |
| Price | $124.84 | $414.44 |
| Today | +1.5% | +0.9% |
| Return YTD | +27.1% | +8.1% |
| Return 1Y | +30.6% | +35.9% |
| P/E | 55.1 | 245.9 |
| P/S | 4.5 | 8.8 |
| P/B | 1.8 | 2.7 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
RevvityRVTY
Newborn and genetic screening is the clinical end of the business; the rest supplies reagents and software to research laboratories.
Full RVTY profile →Waters CorporationWAT
Waters sells liquid chromatography and mass spectrometry systems; pharmaceutical companies and other laboratories buy them along with the consumables and software that keep them running.
Full WAT profile →More RVTY & WAT comparisons
Other head-to-heads in the Life science tools segment.